Showing 1-10 of 14 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Defining and applying neo-epitope specific TCRs for engineered cell therapy | Benaroya Research Institute at Virginia Mason | Aïsha Callebaut | Cures | 01-March-2023 to 28-February-2026 | $205,273.00 |
| Long-read approaches to identify coding, non-coding, and structural variation that contributes to T1D risk | Benaroya Research Institute at Virginia Mason | Eddie James | Cures | 01-September-2024 to 28-February-2026 | $150,000.00 |
| Assessing and mitigating T cell recognition of iPSC derived endocrine cells in Type 1 Diabetes | Benaroya Research Institute at Virginia Mason | Eddie James | Cures | 01-June-2024 to 31-May-2026 | $500,000.00 |
| Cooperative harmonization and validation of an islet-specific AIM assay | Benaroya Research Institute at Virginia Mason | Karen Cerosaletti | Cures | 01-February-2024 to 31-January-2027 | $299,998.00 |
| Early immune and beta cell monitoring predicts treatment response | Benaroya Research Institute at Virginia Mason | S. Alice Long | Cures | 01-August-2019 to 31-July-2025 | $2,499,814.79 |
| Advancing Breakthroughs in Type 1 Diabetes Research with Safe and Immune Cloaked Stem Cells | Pluristyx | Benjamin Fryer | Cures | 15-November-2025 to 14-November-2027 | $704,860.20 |
| Achieving Health in Emerging Adults with Diabetes Program | Seattle Childrens Hospital | Faisal Malik | Improving Lives | 01-September-2024 to 31-August-2028 | $1,734,029.00 |
| Randomized trial of semaglutide for diabetic kidney disease in type 1 diabetes | University of Washington | Ian De Boer | Improving Lives | 01-September-2023 to 31-August-2026 | $2,107,411.00 |
| Thermally responsive minimally invasive proangiogenic placeholder for cell transplantation for Type 1 Diabetes | University of Washington | Patrick Stayton | Cures | 01-November-2025 to 31-October-2028 | $894,965.96 |
| METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) | University of Washington | Petter Bjornstad | Improving Lives | 01-September-2025 to 31-August-2028 | $2,040,014.30 |